
ALFASIGMA ANNOUNCES THE AGREEMENT FOR THE ACQUISITION OF 100% OF SOFAR, ITALIAN PHARMACEUTICAL COMPANY
ALFASIGMA S.p.A. has signed an agreement to acquire the entire share capital of SOFAR
Actueel & Media / Actueel
ALFASIGMA S.p.A. has signed an agreement to acquire the entire share capital of SOFAR
#LeaveYourMark will explore some of our key task: Improving patients' quality of
De Neonatale Hielprik Screening (NHS) is in 1974 in Nederland ingevoerd en
Hier vind u informatie over onze producten en binnenkort ook meer informatie
Chief Executive Officer of Alfasigma, Pier Vincenzo Colli, has decided to leave the
Over 17 million EUR invested in LABIO 4.0 Marino Golinelli Two days
Alfasigma, Utopia SIS, Istituto David Chiossone and Club2021 will invest 6 million euros
About Carnitine is the leading online global destination for healthcare professionals worldwide, offering
The merger between the 3 Italian companies Alfa Wassermann, Sigma-Tau and Biofutura
You’re entering Alfasigma global website
I agree